RACHEL LEBRUN: Open Payments
NPI 1225407976 · RANCHO MIRAGE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$442 in 11 payments from 7 companies in 2025. Trend: 2023 $257 · 2024 $406 · 2025 $442
Food & beverage: $442
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $217 |
| Aveo Pharmaceuticals, Inc. | 3 | $84 |
| AstraZeneca Pharmaceuticals LP | 2 | $53 |
| ABBVIE INC. | 1 | $28 |
| Celgene Corporation | 1 | $27 |
| Tempus AI, Inc | 1 | $19 |
| SOBI, INC | 1 | $15 |
Products named: IMDELLTRA (AMG757), FOTIVDA, CALQUENCE, EPKINLY, REBLOZYL, XT CDX, Vonjo.
Industry payments across CA — which companies pay providers there.
